Dipna Pharmachem independent director resigns effective June 10
Dipna Pharmachem Limited accepted the resignation of Nandish Shaileshbhai Jani as Non-Executive and Independent Director effective June 10, 2026. Jani cited personal reasons for stepping down and confirmed no other material reasons for his departure. He holds directorships in Magenta Lifecare Limited and AKI India Limited.
*this image is generated using AI for illustrative purposes only.
Dipna Pharmachem Limited accepted the resignation of Nandish Shaileshbhai Jani from the position of Non-Executive and Independent Director effective June 10, 2026. The resignation was submitted due to personal reasons, and the company confirmed there are no other material factors behind the decision.
The disclosure was made to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company received confirmation from Jani that the reasons stated in his resignation letter are exhaustive.
Jani holds directorships in other listed entities, including Magenta Lifecare Limited and AKI India Limited, where he serves as an Independent Director. His roles include chairperson and member positions on key board committees such as Audit, Nomination and Remuneration, and Stakeholders' Relationship committees.
The resignation details were provided in an annexure to the regulatory filing, confirming the effective date and the nature of the director's prior roles. The board acknowledged the resignation and requested the exchange to take note of the change.
Resignation Details
| Particulars | Details |
|---|---|
| Name | Mr. Nandish Shaileshbhai Jani |
| Designation | Non-Executive and Independent Director |
| Reason for Resignation | Personal reason |
| Date of Resignation | June 10, 2026 |
| Director ID (DIN) | 09565657 |
Historical Stock Returns for Dipna Pharmachem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.69% | -2.36% | -21.15% | -54.67% | -76.56% | -78.94% |
Who will Dipna Pharmachem appoint to fill the vacancy left by Nandish Jani on the board?
Will the resignation impact the composition of key board committees such as Audit and Nomination?
Could this resignation signal potential changes in Jani's roles at other listed entities like Magenta Lifecare and AKI India?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
